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ABSTRACT 
Mechanisms underlying the repair of extrahepatic biliary tree (EHBT) after injury 
have been scarcely explored. The aims of this study were to evaluate, by using a 
lineage tracing approach, the contribution of peribiliary gland (PBG) niche in the 
regeneration of EHBT after damage and to evaluate, in vivo and in vitro, the 
signaling pathways involved. Bile duct injury was induced by the administration of 
3,5-Diethoxycarbonyl-1,4-dihydrocollidine (DDC) diet for 14 days to 
Krt19CreTdTomatoLSL mice. Human Biliary Tree Stem Cells (BTSC) within PBGs 
were isolated from extrahepatic biliary tree obtained from liver donors. Hepatic duct 
samples (N=10) were obtained from patients affected by Primary Sclerosing 
Cholangitis (PSC). Samples were analysed by histology, immunohistochemistry, 
western blotting, and PCR. DDC administration causes hyperplasia of PBGs and 
periductal fibrosis in EHBT. A PBG cell population (Cytokeratin19-/Sox9+) is involved 
in the renewal of surface epithelium in injured EHBT. The WNT signalling pathway 
triggers human BTSC proliferation in vitro and influences PBG hyperplasia in vivo in 
the DDC-mediated mouse biliary injury model. The Notch signalling pathway 
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activation induces BTSC differentiation in vitro toward mature cholangiocytes and is 
associated with PBG activation in the DDC model. In human PSC, inflammatory and 
stromal cells trigger PBG activation through the up-regulation of the WNT and Notch 
signalling pathways. Conclusion: we demonstrated the involvement of PBG cells in 
regenerating the injured biliary epithelium and identified the signaling pathways 
driving BTSC activation. These results could have relevant implications on the patho-
physiology and treatment of cholangiopaties. 
 
The biliary tree is a system of interconnected ducts comprising intrahepatic bile ducts 
(IHBDs) and extrahepatic bile ducts (EHBDs). Bile ducts are lined by specialized 
epithelial cells named cholangiocytes(1, 2). Cholangiocytes are involved in the 
modification of bile composition(3) and their proliferation is responsible for the 
turnover of the biliary epithelium(4). However, human diseases affecting the biliary 
tree (i.e. cholangiopathies) determine an impairment of cholangiocyte proliferative 
capabilities(5). In such conditions, the regeneration of interlobular bile duct 
epithelium is supported by hepatic stem/progenitor cells within bile ductules(6, 7). 
Moreover, peribiliary glands (PBGs) within large IHBDs and EHBDs contain a unique 
stem cell niche(8). Biliary tree stem/progenitor cells (BTSCs) in PBGs possess high 
self-renewal and proliferative capabilities(9, 10). However, their role in biliary 
regeneration has not been precisely addressed. In primary sclerosing cholangitis 
(PSC), which involves large IHBDs and EHBDs, cholangiocyte senescence and 
apoptosis are paralleled by BTSC activation followed by PBG hyperplasia in affected 
ducts(11). These aspects suggest a putative contribution of BTSCs in the 
regenerative processes involved in pathologies affecting these portions of the biliary 
tree when cholangiocyte proliferation is impaired. 
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The aims of the present study are: i) to evaluate the contribution of BTSCs in the 
repair of damaged EHBDs by using a mouse lineage tracing model; ii) to evaluate 
the signaling pathways involved in BTSC activation and differentiation both in vitro 
and in vivo; iii) to study the expression of activated signaling pathways within PBGs 
in human PSC samples. 
 
MATERIALS AND METHODS 
Murine model 
The animals in this study were on a C57BL6/J background. Both male and female 
mice were used. All animal experiments were carried out under procedural 
guidelines, severity protocols and with ethical permission from the University of 
Edinburgh Animal Welfare and Ethical Review Body (AWERB) and the Home Office 
(UK). The Krt19CreTdTomatoLSL mice was induced by 3 individual intraperitoneal (i.p.) 
injections of Tamoxifen (20mg/ml, Sigma UK) at the dose of 4mg during the light 
cycle. Animals received two weeks of normal diet after the last Tamoxifen injection 
before commencing the diet regime (T0). 
To induce bile duct injury, mice were given 0.1% 3,5-Diethoxycarbonyl-1,4-
dihydrocollidine (DDC) mixed with Rat & Mouse No1 Maintenance (RM1) diet 
(Special Diet Services), for 14 days. After DDC diet, mice were given normal chow 
and drinking water for the successive 14 and 28 days (recovery period). Mice were 
euthanized: i) after 14 days of DDC diet (DDC group: N=5), ii) after 14 days of 
recovery period (2-wk REC group: N=5), and iii) after 28 days of recovery period (4-
wk REC group: N=5). As control, mice (N= 15) were maintained under a normal 
chow diet for the entire experimental period and sacrificed at the same time of mice 
fed with DDC diet (14, 28, 42 days after T0). 
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The murine extrahepatic biliary tree was dissected and fixed en bloc, as previously 
described(12). 
 
Light microscopy, histopathology and immunohistochemistry 
For immunohistochemistry, sections were incubated overnight at 4°C with primary 
antibodies (Supplementary Table 1). Samples were rinsed twice with PBS, 
incubated at room temperature with secondary biotinylated antibody and then with 
Streptavidin-HRP (LSAB+ System-HRP, code K0690, Dako, Glostrup, Denmark). 
Diaminobenzidine (Dako, Glostrup, Denmark) was used as substrate, and sections 
were counterstained with hematoxylin(13). For immunofluorescence, labeled isotype-
specific secondary antibodies were used (AlexaFluor, Invitrogen, Life Technologies 
Ltd, Paisley, UK) and samples were counterstained with 4,6-diamidino-2-
phenylindole for visualization of cell nuclei(14). For all immunoreactions, negative 
controls (primary antibodies were replaced with pre-immune serum) were included. 
Sections were examined in a coded fashion by Leica Microsystems DM 4500 B Light 
and Fluorescence Microscopy (Leica Microsystems, Weltzlar, Germany), equipped 
with a Jenoptik Prog Res C10 Plus Videocam (Jena, Germany). 
Immunofluorescence stains were also analyzed by Confocal Microscopy (Leica TCS-
SP2). Slides were further processed with an Image Analysis System (IAS - Delta 
Sistemi, Roma, Italy) and were independently evaluated by two researchers in a 
blind fashion. 
 
The thickness of bile duct walls was measured by an Image Analysis System (IAS - 
Delta Sistemi, Rome- Italy). The extension of fibrosis was evaluated in Sirius red 
stains, as previously(15). The volume occupied by PGBs was expressed as the 
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percentage with respect to the total duct wall(8-10). For immunoreactions, the 
number of positive cells was automatically calculated by an algorithm on the entire 
section and, then, a semi-quantitative scoring system was applied (0= <5%; 1= 6–
10%; 2= 11–30%; 3= 31–50%; 4= >50%)(8). The number of Sry-related HMG box 9 
(Sox9)+ cells per field at 20x was calculated in six non-overlapping fields(16). 
 
Human tissue sourcing 
Human extrahepatic biliary tree samples were obtained from the “Paride Stefanini” 
Department of General Surgery and Organ Transplantation, Sapienza University of 
Rome, Rome, Italy(17, 18). Written informed consent to use tissues for research 
purposes was obtained from our transplant program. All samples derived from adults 
between the ages of 19 and 73 years. Protocols received the approval of our 
Institutional Review Board, and processing was compliant with current Good 
Manufacturing Practice. The study protocol was conformed to the Ethical Guidelines 
of the 1975 Declaration of Helsinki. The research protocol was reviewed and 
approved by the Ethic Committees of Policlinico Umberto I of Rome, Italy. No donor 
organs were obtained from executed prisoners or other institutionalised individuals. 
 
BTSC isolation, cell cultures, media and solutions 
BTSCs have been isolated from human organs as previously described(9, 10). As 
control conditions, human (h)BTSC were cultured in a self-replication medium (i.e. 
Kubota’s Medium: KM), as previously(9, 10). The in vitro effects of signalling 
pathway on hBTSC were evaluated by supplementing the Kubota’s medium with 
specific Notch and WNTactivators and inhibitors. The following conditions have been 
tested: 
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• Notch pathway stimulation medium: Notch-M(19). 
• WNT pathway stimulation medium: WNT-M(19). 
• WNT-M + WNT inhibitor: WNT-M + Block(19). 
• LPS: KM supplemented with lipopolysaccharides(20). 
The exact composition of analysed conditions is furnished in supplementary 
materials. Cell proliferation was assessed by MTS assay, DNA Quantification (see 
supplementary materials), and Population Doubling Time (PDT)(20). Cell migration 
has been assessed by Scratch Test (21). 
 
Quantitative reverse-transcription polymerase chain reaction (RT-qPCR) analysis 
Total RNA was extracted from cell cultures by the procedures of Chomczynski and 
Sacchi(22). Subsequently, the mRNA levels was analysed by RT-qPCR as 
previously(17). GAPDH was used as in vitro reference gene. The primer sequences 
are reported in Supplementary Table 2. 
 
Protein extraction and Western Blot analysis 
Proteins were extracted by Ripa buffer added with protease inhibitor cocktail 1:100 
(SIGMA #P8340) and phosphatase inhibitor cocktail 1:100 (SIGMA #P5726). The 
proteins were quantized by Bradford assay using the Protein Assay Dye Reagent 
concentrate (Bio-Rad #500-0006).The protein extracts were resolved by SDS-PAGE 
on a 4-20% polyacrylamide gel (Mini-PROTEAN®TGXTM BIO-RAD #4561021) 
under reducing conditions and subsequently transferred on a nitrocellulose filter by 
0.2 μm (BIO-RAD #1620146). Membranes were blocked overnight at 4°C with 5% 
Marvel skimmed milk in 1xTris Buffered Saline/Tween20 (TBST 20 mM Tris HCL, 
pH=8, 300mM NaCl, 0.1% Tween20) and were incubated 1h at room temperature 
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with primary antibody. Subsequently, membranes were rinsed with TBST and 
incubated for 1h at room temperature with secondary antibody peroxidase 
conjugated. The Light A Bolt Plus (Euroclon) Chemiluminescence System was used 
for detection. Used antibodies are described in Supplementary Table 3. 
 
Statistical Analysis 
Data are indicated as mean±standard deviation. The Student t test or Mann–Whitney 
U test was used to determine differences between groups for normally- or not 
normally-distributed data, respectively. The Pearson correlation coefficient or the 
Spearman nonparametric correlation was used. A p-value of <0.05 was considered 
statistically significant. Analyses were performed using SPSS software (IBM, Milan, 
Italy). 
 
RESULTS 
DDC administration causes PBG hyperplasia and periductal fibrosis in the extra-
hepatic bile ducts 
DDC mice (Figure 1) showed focal disruption of the surface epithelium and a 
marked increase of the wall area fraction occupied by PBGs (PBG area= 15.4±1.9%) 
with respect to normal ducts (3.6±2.7%, p<0.001). Two weeks after recovery from 
DDC injury, the surface epithelium was mostly restored and continuous without 
disruption. After 4 weeks of recovery, PBG area was significantly reduced 
(9.49±1.83%) compared to DDC mice (p<0.01). As far as mucinous cells are 
concerned, DDC-injured ducts presented a marked increase in the number of PAS+ 
cells within PBGs, which returned to control value after the recovery period 
(histogram in Figure 1B). 
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The examination of Proliferating Cell Nuclear Antigen (PCNA) expression (a marker 
of proliferation, Figure 1C) indicated a marked increase in the number of PCNA+ 
cells within PBGs in DDC mice (30.7±4.0%) compared to controls (12.7±2.08%, 
p<0.01). Differently, PCNA expression by surface epithelial cells (i.e. mature 
cholangiocytes) did not significantly increase in DDC mice (9.0±8.5%) compared to 
controls (3.3±1.5%). After recovery from DDC injury, the number of proliferating PBG 
cells returned to control values (p<0.02 versus DDC). 
 
Furthermore, DDC administration induced periductal fibrosis in EHBD walls (Figure 
2); the wall thickness of EHBD walls in DDC mice was greatly increased (118.1±7.1 
µm) compared to control mice (76.9±15.1 µm; p<0.01, Figure 2A); moreover, the 
extent of Sirius Red-stained fibers was increased in EHBD walls of DDC mice 
(0.043±0.018 µm2) compared to controls (0.0018±0.0009 µm2; p<0.01); finally, the 
area fraction of the duct wall occupied by Collagen I was increased in DDC mice 
compared to controls (Figure 2B). When α smooth muscle actin-positive and 
desmin-positive myofibroblasts were counted, DDC mice showed an increase in the 
number of α smooth muscle actin+ and desmin+ myofibroblasts within EHBD walls 
compared to controls (Figure 2C-D). EHBD wall thickness (r= 0.76; p<0.01) and 
fibrillar collagen extent (r= 0.60; p<0.05) were correlated with the PBG area. 
 
The thickness of EHBD walls significantly reduced both after 2 and 4 weeks of 
recovery (108.2±4.3 µm and 106.9±2.9 µm; p<0.05 versus DDC mice). Sirius Red 
stained fiber extent and Collagen I area fraction showed a significant reduction after 
4 weeks of recovery (0.017±0.009 µm2 p<0.05 compared to DDC mice). Similarly, in 
the recovery period, the number of α smooth muscle actin+ and desmin+ 
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myofibroblasts within EHBD walls (Figure 2C-D) was reduced compared to DDC 
mice (p<0.02). 
 
Cytokeratin(K)19-/Sox9+ PBG cell population participates to the renewal of surface 
epithelium in injured EHBT 
The expression and distribution of the stem cell marker Sox9 and mature 
cholangiocyte markers (K19; AE2: anion exchanger 2; CFTR: Cystic Fibrosis 
Transmembrane conductance Regulator) were studied in EHBD. In controls (Figure 
3), virtually all cholangiocytes lining surface epithelium were K19+, CFTR+, AE2+ but 
Sox9-. Most but not all PBG cells expressed K19, and the percentage of K19- cells 
accounted for nearly 5%. Rare PBG cells expressed AE2 and CFTR. PBG contained 
Sox9+ cells that accounted for nearly 10% (8.7±3.2%); a Sox9+ PBG cell 
subpopulation was K19- and located at the bottom of PBGs. 
 
In DDC mice (Figure 3), the percentage of Sox9+ cells increased both in PBGs 
(48.0±5.6%) and in surface epithelium (15.3±6.3%) compared to controls (p<0.05); 
interestingly, surface epithelial cells in DDC mice were K19+ but almost all negative 
for CFTR and AE2. 
 
To investigate the possible role of K19-/Sox9+ PBG cell population in the renewal of 
surface epithelium and mature cholangiocyte turnover, we analyzed a lineage tracing 
system in the DDC model. To label cells we used the Krt19CreERTLSLtdTomato mouse 
and found labelling (td-Tom positivity) strictly specific to the epithelial cells within the 
EHBD. In controls (Figure 4), the percentage of td-Tomato negative (td-Tom-) cells 
in the surface epithelium was low (5.4±2.9%) and td-Tom+ cells lining EHBDs 
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represented >90% of cells; cholangiocytes lining EHBD in normal conditions were 
constantly K19+ and Sox9-, as demonstrated in Figure 3. These observations 
confirmed that the slow physiological turnover of biliary epithelium was achieved by 
the proliferation of mature K19+ cholangiocytes. In DDC mice (Figure 4A), the 
number of K19+/td-Tom- cells within the surface epithelium greatly increased to 
34±8.21% (p<0.001 versus controls). In DDC mice, some td-Tom- cells within 
surface epithelium were Sox9 positive (Figure 4C); contrarily, these cells were 
AE2/CFTR negative, given the demonstrated lack of AE2/CFTR expression in 
surface epithelium of DDC mice (Figure 3). 
 
During recovery phase, the percentage of td-Tom- cells within the surface epithelium 
progressively decreased at 2 and 4 weeks (p<0.05 versus DDC mice) but remained 
significantly higher compared to controls (p<0.05; Figure 4B). td-Tom- cells within 
surface epithelium progressively showed phenotypic features of mature 
cholangiocyte differentiation, such as the loss of Sox9 positivity at 2 weeks (not 
shown) and the appearance of CFTR expression at 4 weeks (Figure 4D). 
 
WNT pathway triggers human BTSC proliferation in vitro and influences PBG 
hyperplasia in DDC-mediated duct injury in mice. 
The in vitro administration of R-spondin 1 (WNT activator) significantly increased 
BTSC proliferation as demonstrated by MTS assay, population doubling time, DNA 
concentration, Cyclin D1 expression, and PCNA gene expression (Figure 5A and 
Supplementary Figure 1); R-spondin 1 also increased cell migration as 
demonstrated by the scratch test (Supplementary Figure 1). The administration of a 
WNT inhibitor prevented these effects. Interestingly, R-spondin 1 administration did 
A
cc
ep
te
d 
A
rt
ic
le
This article is protected by copyright. All rights reserved. 
not change the expression levels of genes related to stemness (Supplementary 
Figure 1). The stimulation of the WNT pathway in BTSCs determined the increased 
expression of non-phosphorylated (Ser45) β-catenin (active) with respect to total 
protein amount as demonstrated by WB analysis and by immunofluorescence 
(Figure 5B-D). In turn, the expression of active β-catenin was also increased by 
stimulating BTSC with Lipopolysaccharides (Figure 5B-D and Supplementary 
Figure 1), a substance proved to have proliferative effects on BTSCs(20). 
The expression of WNT ligands and active β-catenin was further studied in vivo in 
the DDC model. In controls, WNT ligands (Wnt1 and Wnt3a) were rarely expressed 
by stromal cells within the lamina propria of EHBD (Figure 5 and Supplementary 
Figure 1). DDC injury increased the percentage of stromal cells expressing WNT 
ligands around PBGs (p<0.05 versus controls; Figure 5). After the recovery period, 
this significant increase was abolished. In parallel, DDC injury increased active β-
catenin expression by PBGs (p<0.05 versus controls) which returned to the level of 
controls after the recovery period (Figure 5E). 
 
Notch pathway activation in human BTSC induces their differentiation to mature 
cholangiocytes and is associated with PBG activation in DDC-mediated duct injury in 
mice. 
 
The stimulation of Notch pathway by the administration of recombinant human sDLL-
1 determined in BTSCs the increase of Notch intracellular domain (NICD) by WB 
analysis and NOTCH1 expression by immunofluorescence compared to control 
conditions (p<0.05, Figure 6A). The activation of the Notch pathway in BTSCs 
significantly reduced cell proliferation and stem cell gene expression (Figure 6B and 
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Supplementary Figure 2). Remarkably, The Notch pathway activator specifically 
triggered cholangiocyte differentiation as showed by i) the up-regulation of mature 
cholangiocyte genes (i.e. CFTR, SCTR, ASBT) compared to control conditions 
(Figure 6B), and ii) the expression of mature cholangiocyte marker demonstrated by 
western blot analysis (i.e. CFTR, AE2, Figure 6C) and by immunofluorescence (i.e. 
SCTR and presence of primary cilia, Figure 6D). No sign of differentiation towards 
hepatocyte or endocrine pancreatic lineages was detected when cells were 
stimulated by the Notch activator (not shown). 
 
The expression of Notch pathway elements was further studied in vivo in the DDC 
mouse model. In controls, Notch1 (Figure 6E), Notch2 (Supplementary Figure 2), 
but not Notch3 (Supplementary Figure 2) were expressed by few cells within 
PBGs. DDC injury determined a significant increase of the percentage of PBG cells 
expressing Notch1, Notch2, and Notch3 compared to controls (p<0.05). After the 
recovery period, this significant increase was partially reduced, but still higher 
compared to controls (p< 0.05). In parallel, DDC injury increased Jagged1 (a Notch 
ligand) expression both by PBGs and stromal cells (p<0.05 versus controls), which 
returned to control levels after the recovery period. 
 
Human Primary Sclerosing Cholangitis is characterized by modification of WNT and 
Notch pathway expression in PBGs. 
In human PSC samples, PBG area was increased compared to control subjects (i.e. 
liver donors); furthermore, PBGs showed higher percentage of PAS+ (mucinous), 
Sox9+ (stem/progenitor), and PCNA+ (proliferating) cells compared to controls 
(Figure 7A and Supplementary Figure 3). 
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As regard WNT pathway, the ratio between active β-catenin with respect to total β-
catenin expression, quantified in PBGs by an image analysis algorithm, indicated an 
increased activation of β-catenin in PSC compared to control subjects (Figure 7B 
and Supplementary Figure 4-5). Then, to explore in situ the possibility that WNT 
ligands are furnished by inflammatory cells in PSC, we analysed WNT1 and WNT3a 
given their well-known role in influencing the liver stem cell niche(23). Our results 
indicated that WNT1 and WNT3a were mostly expressed by inflammatory cells 
(S100A9+) which surrounded PBGs in PSC-affected ducts (Figure 7C). 
As regard Notch pathway (Figure 7D-F), PBGs in PSC showed a slight increase in 
Notch1 expression compared to control samples. Moreover, Notch2 and Hes1 
nuclear expression was strongly increased in PSC compared to controls. 
Interestingly, when Notch ligands were investigated, the expression of DLL4 and 
Jagged2 was increased in PSC compared to control samples (Figure 7D-F). These 
ligands were expressed by PBG cells, by inflammatory (S100A9+) cells, and by 
stromal (α smooth muscle actin+) cells surrounding PBGs. 
 
Given the high expression of WNT and Notch ligands by inflammatory cells in PSC 
samples, we divided PSC-affected ducts between ducts with high inflammation and 
ducts with low inflammation (Figure 8A-C) based on the presence of more than one 
inflammatory foci per duct. Interestingly, PSC-affected ducts with high inflammation 
were characterized by higher PBG mass compared to PSC ducts with low 
inflammation. In PSC duct with low inflammation, PBGs did not show increased 
expression of active β-catenin and Notch-1 compared to normal ducts (Figure 7). 
Differently, PBGs within highly inflamed ducts showed an increased active β-catenin 
and Notch-1 compared to normal ducts and PSC-affected ducts with low 
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inflammation (p< 0.05). Finally, Notch-2 expression by PBGs was significantly 
increased both in PSC ducts with low and high inflammation compared to control 
ducts (p< 0.05). 
 
DISCUSSION 
The present study demonstrated that: i) DDC injury in mice mimics typical PSC histo-
pathological lesions, including PBG hyperplasia, mucinous metaplasia and periductal 
fibrosis; ii) Sox9+ cells within PBGs proliferate and participate in the regeneration of 
cholangiocytes lining biliary epithelium after DDC-induced damage; iii) WNT triggers 
BTSC proliferation and migration while Notch pathway induces their differentiation 
toward a mature phenotype; iv) in PSC patients, PBG proliferation is associated with 
sustained activation of WNT and Notch pathways by inflammatory and stromal cells. 
Altogether, our results support the involvement of BTSCs located in PBGs in the 
regeneration of the biliary epithelium after injury and in disease progression (Figure 
8D). 
 
In humans, PBGs represent the niche of BTSCs, a stem/progenitor cell population 
with multipotent capabilities. Both in vitro and in vivo, BTSCs can mature towards 
hepatocyte, cholangiocyte and pancreatic lineages(8, 9). PBGs are not distributed 
homogeneously along the entire biliary tree; they are present in extrahepatic biliary 
tree and in larger intrahepatic (i.e. segmental and area) bile ducts(8). The 
involvement of PBGs and BTSCs in biliary tract pathologies has been described in 
experimental models(24) and in human cholangiopathies(25). In ischemic biliary 
lesions, an increased number of proliferating progenitor cells has been demonstrated 
in PBGs(26); the PBG injury due to ischemia is associated with the occurrence of 
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biliary strictures after liver transplantation(27). Interestingly, PBGs are also involved 
in the pathogenesis of biliary strictures in patients with PSC(11, 28); in this disease, 
chronic biliary inflammation stimulates PBG stem cell niche with subsequent 
myofibroblast activation, leading to biliary fibrosis and strictures. Furthermore, PBG 
stem cell niche gives rise to a secondary regenerative response leading to biliary 
carcinogenesis in human PSC patients(20) and in experimental genetically-induced 
biliary injury(29). Generally, the emerging concept is that PBG stem cell niche can be 
activated in the context of pathologies affecting larger IHBDs and EHBDs(8, 30), 
despite the well-recognized proliferative capability of mature cholangiocytes(4, 31). 
Thus, the actual contribution of BTSCs in the bile duct regeneration remains an open 
question. 
 
In this study, biliary injury was experimentally induced in a lineage tracing model. 
Most of experimental model of biliary injury mainly focused on IHBD and liver 
fibrosis(32). In contrast, few studies investigated histological damage of extrahepatic 
ducts and the development of biliary concentric fibrosis (i.e. strictures)(32). Here, we 
observed that DDC administration was able to induce damage and fibrosis in EHBDs 
with histological depicts mimicking PSC lesions, including surface epithelium 
destruction, PBG proliferation and mucinous metaplasia, myofibroblast activation, 
and concentric fibrosis. Other experimental models have been proved to mimic PSC 
(e.g. Mdr2 knockout mice)(32); however, the aims of the present study lead to opt for 
the chemically-induced DDC model instead of genetic ones given the possibility to 
remove the toxic agent and observe the recovery. Interestingly, DDC administration 
induced the expansion of the Sox9+ cell population in PBGs. The Sox9+ cell 
compartment extended towards the surface epithelium which became devoid of 
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AE2+ and CFTR+ (i.e. mature) cholangiocytes. The interruption of the DDC diet 
(recovery period) determined a progressive restoration of the bile duct histology. Our 
lineage tracing system tracked K19+ cholangiocytes with an efficiency around 90% in 
EHBD surface epithelium; following DDC administration, not-tracked cells 
replenished the surface epithelium, thus indicating a substantial participation of K19- 
cells to the regenerative response. In EHBDs, K19- cells were only localized within 
PBGs and corresponded to the Sox9+ cell population. In keeping with that, td-Tom- 
cells within surface epithelium of injured ducts were Sox9+ and CFTR/AE2 negative, 
thus confirming the PBG compartment as a source of surface epithelial cells in 
injured ducts. Interestingly, some Sox9+/td-Tom- cells within surface epithelium 
showed positivity for K19, indicating sign of initial maturation; this feature was 
followed by the progressive loss of Sox9 expression and the appearance of 
functional cholangiocyte markers (i.e. CFTR) during the recovery period. The choice 
to focus on EHBDs excludes the eventual interference of small Sox9+ cholangiocytes 
in our model; small cholangiocytes have proliferative and regenerative capabilities(3, 
33); however, this cell compartment is anatomically distinct from the extrahepatic 
biliary tree since it corresponds to the bile ductules inside the liver parenchyma; 
moreover, small cholangiocytes express K19, thus phenotypically differing from K19- 
PBG subpopulation investigated in this study. Taken together, our data indicate an 
active contribution by Sox9+ PBG cells in the restoration of surface epithelium after 
injury and their capability to differentiate into mature cholangiocytes. Our findings are 
in keeping with the evidence that the regeneration of ischemic injured surface 
epithelium is ensured by BTSC activation in a human ex vivo model(34). 
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Stem cell activation is precisely modulated by molecular signals furnished by a 
specialized niche. In the liver, the hepatic progenitor cell niche is well-characterized 
and the contribution of Notch and WNT pathways has been thoroughly 
demonstrated(19, 23). By the contrary, no information is present regarding the 
signaling pathways which drive BTSC activation. Therefore, the present study further 
evaluated the activation of WNT and Notch pathways, indicating their role in BTSC 
proliferation (WNT/β-catenin) or cholangiocyte fate choice (Notch). In DDC, WNT 
and Notch ligands are furnished by ductal (myo-)fibroblasts around PBGs, thus 
indicating a putative role of these cells in the niche composition. In this experimental 
model, further studies based on direct in vivo inhibition/stimulation of signaling 
pathways would be compelling. However, we pointed our attention on the role of 
these signals in the contest of human cholangiopathies. Previous studies 
demonstrated a divergent activation of the PBG niche in PSC compared to primary 
biliary cholangitis; in primary biliary cholangitis, PBG hyperplasia does not take place 
since the chronic inflammation primarily involves interlobular bile duct, mostly 
sparing large intrahepatic and extrahepatic bile ducts(11). Differently, in PSC, PBG 
niche is activated, especially in ducts with high fibrosis and inflammation(11). The 
present study further describes a prominent activation of WNT and Notch pathways, 
potentially supported by ligands from infiltrating inflammatory cells. PBGs can 
produce themselves Notch ligands, thus suggesting an autocrine effect and a further 
paracrine effect on neighboring (myo-) fibroblasts. Interestingly, previous evidences 
indicated that, in human biliary disease, PBGs can secrete vascular endothelial 
growth factors, influencing the modification of peribiliary vascular plexus in PSC(20) 
and hypoxic conditions(34, 35). Taken together with previous studies(11, 20), our 
results indicate that the activation of PBG niche represents a consequence of toxic 
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or inflammatory biliary damage (Figure 8). In the DDC model, Notch and Wnt 
signalling pathways are turned off once the toxic agent is interrupted, thus 
determining a progressive restoration to the normal condition. In PSC, chronic 
inflammation continuously triggers PBG niche activation; in turn, chronically activated 
PBGs start to produce growth factors (vascular endothelial growth factors)(20, 34, 
35), signals (Sonic Hedgehog, Notch Ligands)(11), and inflammatory cytokines 
(Interleukin-6, Transforming Growth Factor-β), which further stimulate fibrogenetic 
and inflammatory cells. Therefore, this secretory phenotype(36) of PBGs in PSC 
configures a sort of vicious circle, which is more prone to developing concentric 
fibrosis than furnishing coordinated signals for restitutio ad integrum. Our results 
further support the role of PBGs in biliary carcinogenesis in PSC patients; the effects 
on BTSC proliferation and migration by β-catenin activation and the evidence of 
prolonged WNT ligand production by chronic inflammation are in touch with the 
pathogenetic role of WNT pathway in cholangiocarcinoma(37, 38). 
 
In conclusion, the present study furnishes evidence on the direct role of BTSCs in 
the regeneration of injured biliary epithelium and identified WNT and Notch as key 
signaling pathways driving BTSC activation, with relevant implications in the patho-
physiology and clinical management of cholangiopaties. 
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FIGURE LEGENDS 
Figure 1. Biliary damage induces peribiliary gland hyperplasia in rodent extra-
hepatic bile ducts. A) Hematoxylin & Eosin (H&E) stains on control mice (CTR), in 
3,5-Diethoxycarbonyl-1,4-dihydrocollidine (DDC)-fed mice, and 4-week recovery (4-
wkREC) mice. DDC-injured ducts showed a marked increase of the wall area 
fraction occupied by peribiliary glands (PBG, arrows). After the 4-week recovery 
period, PBG area was reduced compared to DDC mice. B) Periodic Acid-Schiff 
(PAS) stain on CTR, DDC and 4-wkREC mice. DDC-injured ducts presented a 
marked increase in the number of PAS+ cells (arrows) within PBGs, which returned 
to control value after the recovery period. C) Immunohistochemistry for Proliferating 
Cell Nuclear Antigen (PCNA) on CTR, DDC and 4-wkREC mice. DDC mice 
displayed a higher number of PCNA+ PBG cells (arrows) compared to CTR, which 
returned to control levels after the recovery period. In histograms, data are reported 
as means and standard deviation; *p<0.05 vs all other groups. Scale bars= 100 µm 
(panels A, B) and 25 µm (C). 
 
Figure 2. Biliary damage induces periductal fibrosis and activation of 
fibrogenetic cells in rodent extra-hepatic bile ducts. A) Sirius Red (SR) stain in 
control mice (CTR), in 3,5-Diethoxycarbonyl-1,4-dihydrocollidine (DDC)-fed mice, 
and 4-week recovery (4-wkREC) mice. DDC administration induced periductal 
fibrosis with increased wall thickness (inset bars) and higher extent of SR stained 
fibers compared to CTR. Wall thickness and SR-stained fiber extent were reduced 
after four weeks of recovery. B) Immunohistochemistry for Collagen I on CTR, DDC 
and 4-wkREC mice. DDC mice displayed a higher extent of the area fraction 
occupied by Collagen I fibers compared to CTR. Collagen I fiber extent was reduced 
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after four weeks of recovery. C) Immunofluorescence for alpha-smooth muscle actin 
(αSMA). DDC-injured ducts showed an increase in the number of αSMA+ 
myofibroblasts (green arrows) per high powered field (HPF) within bile duct wall 
compared to CTR, which returned to control levels after the recovery period. L: bile 
duct lumen. Green arrowheads indicate smooth muscle cells within artery wall 
(positive control for αSMA). Nuclei are displayed in blue. D) Immunofluorescence for 
desmin. DDC-injured ducts showed an increase in the number of desmin+ cells (red 
arrows) per HPF within bile duct wall compared to CTR, which returned to control 
levels after the recovery period. L: bile duct lumen. Nuclei are displayed in blue. In 
histograms, data are reported as means and standard deviation; §p< 0.05 vs all 
other groups; *p<0.05 vs control group. Scale bars= 100 µm (panels A, C) and 25 
µm (panels B, D). 
 
Figure 3. Biliary damage in rodent extra-hepatic bile ducts is characterized by 
the loss of mature cholangiocytes in surface epithelium. A) Double 
Immunofluorescence for Cytokeratin (K)19 and Sox9 in control mice (CTR) and in 
3,5-Diethoxycarbonyl-1,4-dihydrocollidine (DDC)-fed mice. Separate channels are 
provided. In CTR, virtually all cholangiocytes lining surface epithelium were 
K19+/Sox9- (green arrowheads); PBGs were composed of K19+/Sox9+ cells (yellow 
arrows) and Sox9+/K19- cells located at the bottom of PBGs (red arrows). In DDC-
injured ducts, surface epithelium was characterized by the presence of K19+/Sox9+ 
cells (yellow arrowheads). Nuclei are displayed in blue. Original Magnification (OM): 
40x. B) Double immunofluorescence for Anion Exchanger-2 (AE2) and Cystic fibrosis 
transmembrane conductance regulator (CFTR) in CTR, and for CFTR and Sox9 in 
DDC-fed mice. Separate channels are provided. Surface epithelium in CTR ducts 
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was composed of AE2 and CFTR positive cholangiocytes (yellow arrowheads). 
Contrarily, in DDC-injured ducts, surface epithelium cells were negative for CFTR but 
Sox9 positive (red arrowhead). Nuclei are displayed in blue. OM: 40x. C) 
Immunofluorescence for Sox9 in CTR and DDC mice. In DDC mice, the percentage 
of Sox9+ cells increased in PBGs compared to CTR (red arrows). Cells lining surface 
epithelium (i.e. cholangiocytes) were Sox9- in CTR (blue arrowhead) but Sox9+ in 
DDC (red arrowhead). Nuclei are displayed in blue. L: bile duct lumen. OM: 10x. The 
histogram shows mean and standard deviation for the percentage of Sox9+ cells 
within PBGs and surface epithelium (SE). *p<0.05 vs CTR; §p<0.05 vs surface 
epithelium in CTR; ^p<0.05 vs surface epithelium in DDC. 
 
Figure 4. Peribiliary gland cells participate in the renewal of surface epithelium 
in injured extrahepatic biliary tree in mice. A) Double immunofluorescence for td-
Tomato (td-Tom) and cytokeratin (K)19 in control (CTR), Diethoxycarbonyl-1,4-
dihydrocollidine (DDC)-fed, 2-week recovery (2-wkREC), and 4-week recovery (4-
wkREC) Krt19CreTdTomatoLSL mice. Separate channels are provided. In CTR 
mice, most of K19+ surface epithelial cells (>90%) were lineage tracked and co-
expressed td-Tom; only a minority of K19+ cells was not tracked (green arrow). In 
DDC-injured ducts, the number of td-Tom- cells within the K19+ surface epithelium 
greatly increased (green arrows); in DDC, some tdTom-/K19- cells were present 
within surface epithelium (black arrows). During the recovery period, td-Tom-/K19+ 
cells (green arrows) were present within surface epithelium. Dotted line delimitates 
bile duct lumen (L). Original Magnification (OM): 20x. B) The histogram shows mean 
and standard deviation for the percentage of td-Tom- cells within surface epithelium 
(SE). *p<0.05 vs other groups. C) Double immunofluorescence for td-Tom (in green) 
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and Sox9 (in red) in DDC mice. Separate channels are provided. In DDC-injured 
ducts, td-Tom-/Sox9+ were distributed throughout surface epithelium (red arrows). 
Nuclei (Nu) are displayed in blue. OM: 40x. D) Double immunofluorescence for 
Cystic fibrosis transmembrane conductance regulator (CFTR) and td-Tom in 4-
wkREC mice. Separate channels are provided. Only in 4-wkREC mice, td-Tom- cells 
within surface epithelium showed the appearance of CFTR expression (green 
arrows). Nuclei are displayed in blue. OM: 40x. 
 
Figure 5. WNT pathway triggers biliary tree stem/progenitor cell activation. A) 
Proliferation assays in human biliary tree stem/progenitor cells (hBTSCs) cultured in 
Kubota’s Medium (KM), in WNT pathway-stimulation medium (WNT-M), and in WNT-
M plus WNT inhibitor (WNT-M+Block). WNT pathway stimulation significantly 
increased BTSC proliferation as demonstrated by population doubling time (PDT), 
MTS assay, Cyclin D1 expression by Western Blot (WB) analysis, DNA 
concentration, and PCNA gene expression. The administration of a WNT inhibitor 
(WNT-M+Block) prevented this effect. B) WB analysis for non-phosphorylated (Non 
p)-β-catenin (β-cat) and total β-catenin showed an increased expression of non-
phosphorylated (active) form of β-catenin in hBTSCs cultured in WNT-M compared 
to control conditions (KM). C-D) Immunofluorescence and WB analyses for Non p-β-
cat expression by hBTSCs cultured in KM, in WNT-M, and in KM + 
lipopolysaccharides (LPS). Non p-β-cat expression was enhanced in cells under 
WNT-M and in cells stimulated with LPS (a condition proved to induce BTSC 
proliferation). Nuclei in panel C are displayed in blue. Original Magnification (OM): 
20x. E) Double immunofluorescence for cytokeratin (K)19, Wnt3a (upper panels) and 
non p-β-cat (lower panels) in controls (CTR), 3,5-Diethoxycarbonyl-1,4-
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dihydrocollidine (DDC)-fed mice, and four weeks-recovery (4-wkREC) mice. 
Compared to controls, DDC-injured ducts displayed an increased expression of 
Wnt3a (a WNT ligand) in stromal cells (red arrows) around peribiliary glands (PBGs) 
which declined after the recovery period. In parallel, DDC injury increased non p-β-
cat expression by PBGs (yellow arrows), which returned to CTR levels after the 
recovery period. Nuclei are displayed in blue. Original Magnification: 20x. In panels 
C and E, the heat maps show semiquantitative (SQ) score of immunohistochemistry 
or immunofluorescence analyses. In panels A, B and C, data in histograms represent 
means and standard deviation. *p<0.05 vs controls; °p<0.05 vs other groups. GOI: 
Gene of Interest 
 
Figure 6. Notch pathway drives maturation of biliary tree stem/progenitor cells 
into cholangiocyte. A) Western blot (WB) analysis for Notch Intracellular Domain 
(NICD) and immunofluorescence for Notch1 in human biliary tree stem/progenitor 
cells (hBTSC) cultured in Kubota’s Medium (KM) and under Notch pathway-
stimulation medium (Notch-M). WB and immunofluorescence analyses showed an 
increased expression of NICD and Nocth1 in hBTSCs cultured in Notch-M compared 
to control conditions (KM). Nuclei are displayed in blue. Original Magnification (OM): 
20x. B) PCR analysis for PCNA gene and for genes related to cholangiocyte 
differentiation in KM and in Notch-M. The activation of Notch pathway in hBTSCs 
significantly decreased the proliferation marker PCNA compared to control 
conditions (KM). Notch pathway activation significantly increased the expression of 
mature cholangiocyte genes (i.e. SCTR, CFTR and ASBT) in BTSCs compared to 
control conditions (KM). Data are expressed as means and standard deviation. 
*p<0.01 vs KM. C) The WB analysis showed increased expression of CFTR and AE2 
A
cc
ep
te
d 
A
rt
ic
le
This article is protected by copyright. All rights reserved. 
in BTSC stimulated with Notch activator (Notch-M) compared to control condition 
(KM). Data are expressed as means and standard deviation. *p<0.01 vs KM. D) 
Immunofluorescence for Secretin Receptor (SCTR) and α-tubulin in hBTSCs 
cultured in KM and in Notch-M. The stimulation of Notch pathway induced the 
expression of the mature cholangiocyte marker SCTR and increased the number of 
cells displaying a primary cilium (green arrows), compared to self-replication 
conditions (KM). Nuclei are displayed in blue. OM: 20x (left) and 40x (right). E) 
Double immunofluorescence for cytokeratin (K)19 and Notch1 (upper panels), and 
for α smooth muscle actin (αSMA) and Jagged (Jag)1 (lower panels) in control mice 
(CTR), 3,5-Diethoxycarbonyl-1,4-dihydrocollidine (DDC)-fed mice, and four weeks-
recovery (4-wkREC) mice. DDC-injured ducts displayed higher cytoplasmic and 
nuclear (arrows) expression of Notch1 in peribiliary glands (PBGs) compared to 
controls; Notch1 expression is partially reduced after 4-week recovery period. In 
parallel, DDC injury increased Jag1 (a Notch ligand) expression both by PBGs 
(arrows) and stromal cells (arrowheads), which returned to control levels after the 
recovery period. Nuclei are displayed in blue. OM: 20x. The heat map reports the 
semiquantitative (SQ) score of immunofluorescence analyses in CTR, DDC and 4-
wkREC mice. 
 
Figure 7. WNT and Notch pathways in primary sclerosing cholangitis. A) 
Immunohistochemistry for cytokeratin (K)7 (upper panels) and for proliferating cell 
nuclear antigen (PCNA, lower panels) in human normal bile ducts and in primary 
sclerosing cholangitis (PSC)-affected ducts. K7 images showed an increased 
peribiliary gland (PBG) mass in PSC samples compared to normal ones. Original 
Magnification (OM): 20x. PBGs in PSC displayed higher expression of PCNA 
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(arrows) compared to controls. OM: 40x. B) Image analysis algorithm output of 
immunohistochemistry for non-phosphorylated (Non p-) β-catenin (β-cat) and total β-
cat on normal and PSC-affected ducts; yellow, orange, and red colours indicate 
weak, intermediate and strong positivity, as assessed by an image analysis software. 
The ratio between non p-β-cat and total β-cat expression indicated an increased 
activation of β-cat in PSC samples compared to control subjects. OM: 20x. C) 
Double immunofluorescence for S100A9 and Wnt1 (panels on the left), and for 
S100A9 and Wnt3a (panels on the right) in PSC-affected ducts. In PSC-affected 
ducts, Wnt1 and Wnt3a were mostly expressed by inflammatory (S100A9+) cells 
(arrows) infiltrating bile ducts and located around PBGs. Separate channels are 
provided. OM: 40x. D) Immunohistochemistry for Notch1, Notch2, and Hes1 in 
human normal bile ducts and PSC-affected ducts. PBGs in PSC showed a slight 
increase of Notch1 nuclear expression (arrows) but strong increase of Notch2 and 
Hes1 nuclear expression (arrows) compared to normal samples. OM: 40x. E) In 
upper images, immunofluorescence for Jagged (Jag)2 and for Delta Like Ligand 
(DLL) 4 in human PSC-affected ducts is reported. PBGs (white asterisks) in PSC 
showed expression of Notch ligands (arrows). DLL4 is also expressed by stroma 
cells (arrowhead) around PBGs. OM: 40x. Images in the middle represent double 
immunofluorescence for α Smooth Muscle Actin (αSMA) and Jag2 in PSC-affected 
ducts. αSMA+ myofibroblasts (arrowheads) and PBGs (arrows) in PSC expressed 
Jag2. In lower images, double immunofluorescence for S100A9 and DLL4 in PSC-
affected ducts is displayed. S100A9+ inflammatory cells around PBGs expressed 
DLL4 (arrowheads). Separate channels are provided. OM: 40x. F) Heat map 
visualizing semiquantitative (SQ) score of immunohistochemical and 
immunofluorescence analyses in human normal ducts and PSC-affected ducts. In 
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immunofluorescence images, white asterisks individuate PBGs and nuclei are 
displayed in blue. 
 
Figure 8. WNT and Notch pathways in primary sclerosing cholangitis. A) Sirius 
Red (SR) stains (upper panels) and immunohistochemistry for cytokeratin (K)7 
(lower panels) in primary sclerosing cholangitis (PSC)-affected bile ducts. PSC ducts 
with high inflammation were characterized by higher peribiliary gland (PBG) mass 
compared to PSC ducts with low inflammation (arrows). Asterisks individuate 
inflammatory foci. Original Magnification (OM): 10x B) Immunohistochemistry for 
non-phosphorylated (non p-) β-catenin, Notch1, and Notch2 in PSC-affected ducts. 
PBGs within highly-inflamed ducts showed increase in non p-β-catenin and Notch-1 
compared to PSC ducts with low inflammation. Notch-2 was strongly expressed by 
PBGs both in PSC ducts with low and high inflammation. Arrows point positive 
PBGs. OM: 40x. C) The heat map shows semiquantitative (SQ) scores of 
immunohistochemical analyses in examined PSC-affected ducts. D) Graphical 
abstract of main results obtained in the present study. In vivo, the Sox9+ PBG cell 
population participates to surface epithelial (SE) regeneration in damaged ducts by 
generation of cells with mature cholangiocyte traits. The contribution of PBG cells in 
this model is driven by WNT and Notch pathway activation. In vitro, WNT and Notch 
pathways can induce, respectively, proliferation/migration and cholangiocyte 
differentiation in Biliary Tree Stem Cells (BTSC). In human PSC, biliary strictures are 
due to bile duct wall fibrosis. This and previous studies indicated that WNT and 
Notch pathways have a putative role in the vicious circle at the basis of bile duct 
fibrosis by mutual influencing PBGs, inflammatory cells, myofibroblasts and 
microvessels. SHH: Sonic Hedgehog, IL-6: interleukin-6, TGF-β: Transforming 
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Growth Factor β, VEGFs: Vascular Endothelial Growth Factors; DDC: 3,5-
Diethoxycarbonyl-1,4-dihydrocollidine.  
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